PSIMCT-1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.805400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.979600E-01
Normal-vs-Stage2
8.760000E-01
Normal-vs-Stage3
5.360600E-01
Normal-vs-Stage4
1.737170E-01
Stage1-vs-Stage2
3.124800E-01
Stage1-vs-Stage3
2.901400E-01
Stage1-vs-Stage4
6.156800E-01
Stage2-vs-Stage3
3.738200E-01
Stage2-vs-Stage4
9.603800E-02
Stage3-vs-Stage4
2.070100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.404400E-01
Normal-vs-AfricanAmerican
6.377200E-01
Normal-vs-Asian
2.852000E-01
Caucasian-vs-AfricanAmerican
9.160200E-01
Caucasian-vs-Asian
3.280400E-02
AfricanAmerican-vs-Asian
3.922300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.093000E-01
Normal-vs-Female
8.826600E-01
Male-vs-Female
3.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.975200E-01
Normal-vs-Age(41-60Yrs)
5.757800E-01
Normal-vs-Age(61-80Yrs)
8.714000E-01
Normal-vs-Age(81-100Yrs)
8.393600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.300200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.278430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.531980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.804590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.442360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.601200E-01
Normal-vs-Daily Drinker
6.127800E-01
Normal-vs-Weekly Drinker
9.530800E-01
Normal-vs-Occasional Drinker
5.861800E-01
Normal-vs-Social Drinker
6.505200E-01
Non Drinker-vs-Daily Drinker
8.913600E-02
Non Drinker-vs-Weekly Drinker
6.481400E-01
Non Drinker-vs-Occasional Drinker
5.336000E-01
Non Drinker-vs-Social Drinker
5.278200E-01
Daily Drinker-vs-Weekly Drinker
3.206000E-01
Daily Drinker-vs-Occasional Drinker
4.429800E-02
Daily Drinker-vs-Social Drinker
1.392760E-01
Weekly Drinker-vs-Occasional Drinker
3.703600E-01
Weekly Drinker-vs-Social Drinker
3.903800E-01
Occasional Drinker-vs-Social Drinker
8.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
3.957800E-01
Grade 1-vs-Grade 3
8.977400E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
1.387580E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.811200E-01
Normal-vs-NonDiabetic
8.406400E-01
Diabetic-vs-NonDiabetic
8.117800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.909400E-01
Normal-vs-NoPancreatitis
8.434600E-01
Pancreatitis-vs-NoPancreatitis
6.249600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.399400E-01
Normal-vs-N1
8.889800E-01
N0-vs-N1
1.698560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.395600E-01
Normal-vs-TP53-NonMutant
5.828200E-01
TP53-Mutant-vs-TP53-NonMutant
7.254000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
